Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
South Korea · Delayed Price · Currency is KRW 5,280.00
+160.00 (3.13%)
At close: Jul 10, 2026
Sinil Pharmaceutical Market Cap
Sinil Pharmaceutical has a market cap or net worth of 60.07 billion as of July 10, 2026. Its market cap has decreased by -20.24% in one year.
Market Cap
60.07B
Enterprise Value
22.02B
Revenue
82.18B
Ranking
n/a
PE Ratio
8.78
Stock Price
5,280.00
Market Cap Chart
Since November 20, 2000, Sinil Pharmaceutical's market cap has increased from 16.83B to 60.07B, an increase of 256.97%. That is a compound annual growth rate of 5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 60.07B | -13.01% |
| Dec 30, 2025 | 69.05B | -5.60% |
| Dec 30, 2024 | 73.15B | -16.60% |
| Dec 28, 2023 | 87.71B | -9.43% |
| Dec 29, 2022 | 96.84B | -24.53% |
| Dec 30, 2021 | 128.31B | -48.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daehan Nupharm | 80.42B |
| Sam-A Pharm. | 78.24B |
| Polaris AI Pharma | 76.38B |
| Hwail Pharmaceutical | 71.89B |
| Optipharm.CO.,LTD | 69.02B |
| Pharos iBio | 68.87B |
| Sinsin Pharmaceutical | 67.05B |
| GL Pharm Tech | 65.30B |